Anti | 農藥百科
Asmallclinicaltrialofclemastinefumarate,acommon,over-the-counterallergymedication,hasbeenconductedinpeoplewithMSandhasshownexciting ...
A small clinical trial of clemastine fumarate, a common, over-the-counter allergy medication, has been conducted in people with MS and has shown exciting evidence for myelin repair.
The results of the trial conducted Dr Ari Green, Professor Jonah Chan and their colleagues at University of California San Francisco (UCSF), were published last week in the top medical journal The Lancet[1].
The clinical effects seen in the trial were modest, but this is the first time a trial for myelin repair has shown efficacy in people with MS.
In MS, the myelin sheaths that surround nerve fibres in the brain, spinal cord and optic nerves are damaged by the immune system. Myelin helps nerves to conduct their electrical signals in a fast and efficient manner. Damage to myelin drastically slows down signalling, resulting in the many different neurological symptoms of MS.
C...